Latest News

• share
• favorite_border

• share
• favorite_border

Cedars-Sinai has announced a partnership with the LA28 Olympic and Paralympic Games to serve as the Official Medical Provider for the 2028 Games, providing the highest-quality care for athletes, coaches, team personnel and visitors who travel across the world for the competitions in Los Angeles.

• share
• favorite_border

Cedars-Sinai ha anunciado hoy su asociación con los Juegos Olímpicos y Paralímpicos de LA28 para fungir como proveedor médico oficial de los Juegos de 2028, proporcionando atención de la más alta calidad a los atletas, entrenadores, personal del equipo y visitantes que viajen de todo el mundo con motivo de las competencias en Los Ángeles.

• share
• favorite_border

Dermot McGovern, MD, PhD, director of Translational Research in the F. Widjaja Inflammatory Bowel Disease Institute at Cedars-Sinai, has been awarded the prestigious Sherman Prize for his pioneering work in advancing understanding of the genetic architecture of inflammatory bowel disease (IBD) and applying that knowledge to deliver personalized medicine to patients.

• share
• favorite_border

The most common trauma injuries at Cedars-Sinai are the result of age-related falls. That’s why Gregory Jones, RN, injury prevention and outreach coordinator for the hospital’s Trauma Program, is on a mission to help older adults avoid risk factors and prevent falls.

• share
• favorite_border

Amid southern california’s recent record-breaking heat wave and fast-moving wildfires, public health officials reported the third locally acquired case of dengue fever in the los angeles area. Although the events seem unrelated, they actually are connected—and for troubling reasons.

• share
• favorite_border

Babies born with a narrowed blood vessel now have a device specifically designed for them, thanks to research conducted in the Smidt Heart Institute and Guerin Children’s at Cedars-Sinai.

• share
• favorite_border

Heitham Hassoun, MD, chief executive of Cedars-Sinai International, will be awarded the 2024 International Healthcare Leadership Award by the National Center for Healthcare Leadership (NCHL).

• share
• favorite_border

When Cedars-Sinai Guerin Children’s launched in 2022, it sought to build a pioneering children’s health destination that combined multidisciplinary excellence in pediatric care with advanced research to identify and treat the roots of childhood diseases.

• share
• favorite_border

The Cedars-Sinai Board of Governors Regenerative Medicine Institute is creating a resource laboratory to help advance stem cell-based technologies throughout Cedars-Sinai and across California.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Staging of patients with early pancreatic cancer is inaccurate as much as 80% of the time, according to a new Cedars-Sinai Cancer study published in the peer-reviewed journal JAMA.

• share
• favorite_border

Investigators involved in a multicenter study co-led by Cedars-Sinai discovered a pathway by which immune cells prevent the lungs’ protective barrier from healing after viral infections like COVID-19. The findings, published in Nature, may lead to new therapeutic treatment options.

• share
• favorite_border

George Berci, MD, led an improbable and monumental life. As a young man, he survived the Holocaust and went on to become an internationally renowned surgical pioneer who developed many of the minimally invasive tools and techniques that are used in operating rooms and procedure suites around the world today.

• share
• favorite_border

Back to school, cooler weather, a whiff of pumpkin spice in the air. Yes, it’s flu shot time.

• share
• favorite_border

A new Cedars-Sinai study shows how microorganisms in the human gut can trigger constipation in some people.

• share
• favorite_border

Three recently published studies from Cedars-Sinai investigators have deepened knowledge of how changes in the eye are linked to indicators of Alzheimer’s disease in the brain.

• share
• favorite_border

Cardiac physicians and investigators from the Smidt Heart Institute at Cedars-Sinai will share new research and clinical insights at the European Society of Cardiology Congress in London Aug. 30 through Sept. 2.

• share
• favorite_border

Nirdesh K. Gupta, PhD, has been named the new managing partner of the Cedars-Sinai Intellectual Property Company (CSIP Co.). The new role recognizes Gupta’s expanded scope of management responsibilities over Cedars-Sinai’s technology transfer, venture building, investments and other intellectual property-related initiatives at CSIP Co.